Friday, March 1, 2024 | 2pm
About this Event
Hemann lab I "Utilizing in vivo genome-wide crispr-cas9 screens in an immunocompetent mouse model of glioblastoma to identify novel tumor liabilities and explore mechanismofresistance to car-t”
Event Type
Department
2 people are interested in this event
or